Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Ricart

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
Alimentary Pharmacology & Therapeutics|October 23, 2018
Persistent damage on magnetic resonance enterography in patients with Crohn's disease in endoscopic remissionJordi Rimola, Ignacio Alfaro, Agnès Fernández-Clotet, et al.
Alimentary Pharmacology & Therapeutics|September 4, 2020
Pre-treatment magnetic resonance enterography findings predict the response to TNF-alpha inhibitors in Crohn's diseaseJordi Rimola, Agnès Fernàndez-Clotet, Nunzia Capozzi, et al.
The American Journal of Gastroenterology|July 24, 2002
N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitisElena Ricart, William R Taylor, Edward V Loftus, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2024
Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long-term adverse outcomes in Crohn's diseaseAgnès Fernández-Clotet, Ingrid Ordás, Maria Carme Masamunt, et al.
Journal of Crohn'S & Colitis|February 22, 2020
Validation of the Simplified Magnetic Resonance Index of Activity [sMARIA] Without Gadolinium-enhanced Sequences for Crohn's DiseaseNunzia Capozzi, Ingrid Ordás, Agnès Fernandez-Clotet, et al.
Gut|November 9, 2012
Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterationsNúria Planell, Juan J Lozano, Rut Mora-Buch, et al.
The American Journal of Gastroenterology|January 28, 2015
Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imagingJordi Rimola, Núria Planell, Sonia Rodríguez, et al.
Hepatology (Baltimore, Md.)|April 30, 2003
Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascitesJavier Sola-Vera, Josep Miñana, Elena Ricart, et al.
United European Gastroenterology Journal|July 18, 2025
Volumetric Changes in Perianal Fistulizing Crohn's Disease Measured by Magnetic Resonance Is Feasible and Could Be a Potential Biomarker to Predict Clinical OutcomesBerta Caballol, Ingrid Ordás, Carolina Saavedra, et al.
Inflammatory Bowel Diseases|May 22, 2013
Addition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn's disease: a randomized, double-blind, placebo-controlled trialMíriam Mañosa, Eduard Cabré, Isabel Bernal, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Alimentary Pharmacology & Therapeutics|October 23, 2018
Persistent damage on magnetic resonance enterography in patients with Crohn's disease in endoscopic remissionJordi Rimola, Ignacio Alfaro, Agnès Fernández-Clotet, et al.
Alimentary Pharmacology & Therapeutics|September 4, 2020
Pre-treatment magnetic resonance enterography findings predict the response to TNF-alpha inhibitors in Crohn's diseaseJordi Rimola, Agnès Fernàndez-Clotet, Nunzia Capozzi, et al.
The American Journal of Gastroenterology|July 24, 2002
N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitisElena Ricart, William R Taylor, Edward V Loftus, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2024
Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long-term adverse outcomes in Crohn's diseaseAgnès Fernández-Clotet, Ingrid Ordás, Maria Carme Masamunt, et al.
Journal of Crohn'S & Colitis|February 22, 2020
Validation of the Simplified Magnetic Resonance Index of Activity [sMARIA] Without Gadolinium-enhanced Sequences for Crohn's DiseaseNunzia Capozzi, Ingrid Ordás, Agnès Fernandez-Clotet, et al.
Gut|November 9, 2012
Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterationsNúria Planell, Juan J Lozano, Rut Mora-Buch, et al.
The American Journal of Gastroenterology|January 28, 2015
Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imagingJordi Rimola, Núria Planell, Sonia Rodríguez, et al.
Hepatology (Baltimore, Md.)|April 30, 2003
Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascitesJavier Sola-Vera, Josep Miñana, Elena Ricart, et al.
United European Gastroenterology Journal|July 18, 2025
Volumetric Changes in Perianal Fistulizing Crohn's Disease Measured by Magnetic Resonance Is Feasible and Could Be a Potential Biomarker to Predict Clinical OutcomesBerta Caballol, Ingrid Ordás, Carolina Saavedra, et al.
Inflammatory Bowel Diseases|May 22, 2013
Addition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn's disease: a randomized, double-blind, placebo-controlled trialMíriam Mañosa, Eduard Cabré, Isabel Bernal, et al.
Pageof 14